Met Life Investment Management, LLC Beam Therapeutics Inc. Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 46,900 shares of BEAM stock, worth $915,488. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,900

Previous 43,534 7.73%

Holding current value

$915,488

Previous $1.07 Million 9.1%

% of portfolio

0.01%

Previous 0.01%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$21.55 - $30.35 $72,537 - $102,158	3,366 Added 7.73%	46,900 $1.16 Million
Q2 2024 Aug 13, 2024	BUY	$21.22 - $32.66 $115,649 - $177,996	5,450 Added 14.31%	43,534 $1.02 Million
Q1 2024 May 14, 2024	BUY	$23.46 - $45.07 $893,450 - $1.72 Million	38,084 New	38,084 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $36,335 - $63,181	2,054 Added 5.7%	38,084 $1.04 Million
Q3 2023 May 09, 2024	BUY	$23.01 - $32.46 $60,746 - $85,694	2,640 Added 7.91%	36,030 $866,000
Q2 2023 Apr 29, 2024	BUY	$29.32 - $35.99 $1.06 Million - $1.3 Million	36,030 New	36,030 $1.15 Million
Q2 2023 Aug 10, 2023	BUY	$29.32 - $35.99 $77,404 - $95,013	2,640 Added 7.91%	36,030 $1.15 Million
Q1 2023 May 09, 2024	BUY	$30.15 - $48.79 $1.01 Million - $1.63 Million	33,390 New	33,390 $1.02 Billion
Q4 2022 May 10, 2024	SELL	$36.73 - $51.6 $36,325 - $51,032	-989 Reduced 2.88%	33,390 $1.31 Million
Q4 2022 Mar 22, 2023	SELL	$36.73 - $51.6 $36,325 - $51,032	-989 Reduced 2.88%	33,390 $1.31 Million
Q4 2022 Feb 15, 2023	SELL	$36.73 - $51.6 $36,325 - $51,032	-989 Reduced 2.88%	33,390 $1.31 Million
Q3 2022 May 10, 2024	BUY	$39.79 - $70.31 $52,721 - $93,160	1,325 Added 4.01%	34,379 $1.64 Million
Q3 2022 Jun 14, 2023	BUY	$39.79 - $70.31 $39,352 - $69,536	989 Added 2.96%	34,379 $1.64 Million
Q3 2022 Mar 22, 2023	BUY	$39.79 - $70.31 $52,721 - $93,160	1,325 Added 4.01%	34,379 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $52,721 - $93,160	1,325 Added 4.01%	34,379 $1.64 Million
Q2 2022 May 10, 2024	BUY	$29.86 - $62.36 $176,920 - $369,483	5,925 Added 21.84%	33,054 $1.28 Million
Q2 2022 Jun 20, 2023	SELL	$29.86 - $62.36 $10,032 - $20,952	-336 Reduced 1.01%	33,054 $1.28 Million
Q2 2022 Mar 22, 2023	BUY	$29.86 - $62.36 $176,920 - $369,483	5,925 Added 21.84%	33,054 $1.28 Million
Q2 2022 Aug 11, 2022	BUY	$29.86 - $62.36 $176,920 - $369,483	5,925 Added 21.84%	33,054 $1.28 Million
Q1 2022 May 10, 2024	BUY	$53.73 - $82.16 $1.46 Million - $2.23 Million	27,129 New	27,129 $1.55 Million
Q1 2022 Jun 20, 2023	SELL	$53.73 - $82.16 $336,403 - $514,403	-6,261 Reduced 18.75%	27,129 $1.55 Million
Q1 2022 Mar 22, 2023	BUY	$53.73 - $82.16 $528,112 - $807,550	9,829 Added 56.82%	27,129 $1.55 Million
Q1 2022 May 12, 2022	BUY	$53.73 - $82.16 $528,112 - $807,550	9,829 Added 56.82%	27,129 $1.55 Million
Q4 2021 Jun 21, 2023	SELL	$68.02 - $99.06 $1.09 Million - $1.59 Million	-16,090 Reduced 48.19%	17,300 $1.38 Million
Q3 2021 May 17, 2024	BUY	$84.37 - $133.6 $41,931 - $66,399	497 Added 2.96%	17,300 $1.51 Million
Q3 2021 Jun 21, 2023	SELL	$84.37 - $133.6 $1.36 Million - $2.15 Million	-16,090 Reduced 48.19%	17,300 $1.51 Million
Q3 2021 Mar 22, 2023	BUY	$84.37 - $133.6 $41,931 - $66,399	497 Added 2.96%	17,300 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $41,931 - $66,399	497 Added 2.96%	17,300 $1.51 Million
Q2 2021 May 17, 2024	BUY	$64.12 - $128.71 $91,755 - $184,184	1,431 Added 9.31%	16,803 $2.16 Million
Q2 2021 Jun 21, 2023	SELL	$64.12 - $128.71 $1.06 Million - $2.13 Million	-16,587 Reduced 49.68%	16,803 $2.16 Million
Q2 2021 Mar 22, 2023	BUY	$64.12 - $128.71 $91,755 - $184,184	1,431 Added 9.31%	16,803 $2.16 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $91,755 - $184,184	1,431 Added 9.31%	16,803 $2.16 Million
Q1 2021 May 17, 2024	SELL	$71.28 - $120.75 $1.62 Million - $2.74 Million	-22,712 Reduced 59.64%	15,372 $1.23 Million
Q1 2021 Jun 26, 2023	SELL	$71.28 - $120.75 $1.28 Million - $2.18 Million	-18,018 Reduced 53.96%	15,372 $1.23 Billion
Q4 2020 Jun 22, 2023	SELL	$22.24 - $95.63 $400,720 - $1.72 Million	-18,018 Reduced 53.96%	15,372 $1.25 Million
Q3 2020 May 24, 2024	BUY	$19.0 - $30.57 $166,269 - $267,518	8,751 Added 132.17%	15,372 $378 Million
Q3 2020 Jun 26, 2023	SELL	$19.0 - $30.57 $342,342 - $550,810	-18,018 Reduced 53.96%	15,372 $378,000
Q3 2020 Mar 22, 2023	BUY	$19.0 - $30.57 $166,269 - $267,518	8,751 Added 132.17%	15,372 $378,000
Q3 2020 Nov 13, 2020	BUY	$19.0 - $30.57 $166,269 - $267,518	8,751 Added 132.17%	15,372 $378,000
Q2 2020 May 24, 2024	SELL	$15.26 - $28.66 $480,125 - $901,729	-31,463 Reduced 82.61%	6,621 $185 Million
Q2 2020 Jun 26, 2023	SELL	$15.26 - $28.66 $408,494 - $767,199	-26,769 Reduced 80.17%	6,621 $185,000
Q1 2020 Jul 12, 2023	SELL	$13.31 - $29.2 $356,295 - $781,654	-26,769 Reduced 80.17%	6,621 $119,000
Q1 2020 Mar 22, 2023	SELL	$13.31 - $29.2 $356,295 - $781,654	-26,769 Reduced 80.17%	6,621 $119,000
Q1 2020 May 15, 2020	BUY	$13.31 - $29.2 $88,125 - $193,333	6,621 New	6,621 $119,000

Others Institutions Holding BEAM

# of Institutions

253

Shares Held

78.9M

Call Options Held

304K

Put Options Held

142K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.37B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Beam Therapeutics Inc. Transaction History